Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis

Rheumatology

Volumn 38, Issue 9, 1999, Pages 841-847

  Oelzner, P ^a   Franke, S ^a   Muller A ^a   Hein, G ^a   Stein, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Osteoporosis; Pro inflammatory cytokines; PTH; Rheumatoid arthritis; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIFEDIOL; CALCITRIOL; CYTOKINE; DEOXYPYRIDINOLINE; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; PARATHYROID HORMONE; PYRIDINOLINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE METABOLISM; BONE TURNOVER; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; URINARY EXCRETION;

AGED; AGING; ARTHRITIS, RHEUMATOID; BONE AND BONES; BONE RESORPTION; CALCIFEDIOL; CALCITRIOL; CALCIUM; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; RECEPTORS, INTERLEUKIN-2; SERUM ALBUMIN;

EID: 0032748843     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.9.841     Document Type: Article

References (41)

1. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 1996;35:309-22.
2. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
3. Gough A, Sambrook P, Devlin J, Huisson A, Njeh C, Robbins S et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998;25:1282-9.
4. Laan RFJM, Buijs WCAM, Verbeek ALM. Bone mineral density in patients with recent onset rheumatoid arthritis. Influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6.
5. Oelzner P, Müller A, Deschner F, Hüller M, Abendroth K, Hein G et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1998;62:193-8.
6. Müller K, Odum N, Bendtzen K. 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 1993; 35:177-82.
7. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995;16:200-57.
8. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P. Interleukin-1β stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 1991;10:15-21.
9. Kuroki T, Shingu M, Koshihara Y, Nobunaga M. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. Br J Rheumatol 1994;33:224-30.
10. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-11.
11. Ralston SH. The Michael Mason Prize Essay 1997. Nitric oxide and bone: what a gas! Br J Rheumatol 1997; 36:831-8.
12. Hukkanen M, Hughes FJ, Buttery LD, Gross SS, Evans TJ, Seddon S et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 1995;136:5445-53.
13. Pacifici R. Cytokines and osteoclast activity. Calcif Tissue Int 1995;56(suppl. 1):S27-8.
14. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM et al. Interleukin (IL)-6 induction of osteo-clast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 1995;182:1461-8.
15. Arnett FC, Edworthy SM, Bloch DA. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
16. Müller A, Hein G, Franke S, Herrmann D, Henzgen S, Roth A et al. Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography. Rheumatol Int 1996;16:23-8.
17. Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 1985;28:25-31.
18. Kroger H, Arnala I, Rehnberg V, Hamalainen M, Alhava E. Histomorphometry of periarticular bone in rheumatoid arthritis. Ann Chir Gynaecol 1994;83:56-62.
19. Hein G, Franke S, Müller A, Braunig E, Eidner T, Stein G. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis. Clin Rheumatol 1997;16:167-72.
20. Gough AKS, Peel NFA, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994;53:14-7.
21. Astbury C, Bird HA, McLaren AM, Robins SP. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994; 33:11-5.
22. Burmester GR, Stuhlmüller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid arthritis. Arthritis Rheum 1997;40:5-18.
23. Kotake S, Higaki M, Sato K, Himeno S, Morita H, Kim KJ et al. Detection of myeloid precursors (granulocyte/macrophage colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints. J Rheumatol 1992;19:1511-6.
24. Seitz M, Zwicker M, Pichler W, Gerber N. Activation and differentiation of myelomonocytic cells in rheumatoid arthritis and healthy individuals - evidence for antagonistic in vitro regulation by interferon-gamma and tumor necrosis factor alpha, granulocyte monocyte colony stimulating factor and interleukin 1. J Rheumatol 1992;19:1038-44.
25. Suzuki Y, Tanihara M, Ichikawa Y, Osanai A, Nakagawa M, Ide M et al. Periarticular osteopenia in adjuvant induced arthritis: role of interleukin-1 in decreased osteogenic and increased resorptive potential of bone marrow cells. Ann Rheum Dis 1995;54:484-90.
26. Tanabe M, Ochi T, Tomita T, Suzuki R, Sakata T, Shimaoka Y et al. Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis. J Rheumatol 1994; 21:830-5.
27. Fujikawa Y, Sabokbar A, Neale S, Athanasou NA. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 1996;55:816-22.
28. Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996;11:88-95.
29. Toritsuka Y, Nakamura N, Lee SB, Hashimoto J, Yasui N, Shino K et al. Osteoclastogenesis in iliac bone marrow of patients with rheumatoid arthritis. J Rheumatol 1997; 24:1690-6.
30. Bauer J, Lengyel G, Thung SN, Jonas U, Gerok W, Acs G. Human fetal hepatocytes respond to inflammatory mediators and excrete bile. Hepatology 1991;13:1131-41.
31. Papanicolaou DA. The pathophysiologic roles of interleukin-6 in human disease. NIH conference. Ann Intern Med 1998;128:127-37.
32. Wemeau JL. Calciotropic hormones and ageing. Horm Res 1995;43:76-9.
33. 3 and its analogues: mechanisms of action and possible clinical application. In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D - chemistry, biology and clinical applications of the steroid hormone. Proceedings of the Tenth Workshop on Vitamin D, Strasbourg, France, May 24-29, 1997:507-10.
34. Mawer EB, Hayes ME, Still PE, Davies M, Lumb GA, Palit J et al. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J Bone Miner Res 1991;6:733-9.
35. Hayes ME, Bayley D, Still P, Palit J, Denton J, Freemont AJ et al. Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis. Ann Rheum Dis 1992;51:220-6.
36. Smith SJ, Hayes ME, Mawer EB. Stimulation of 25-hydroxyvitamin-D-24-hydroxylase in synovial fibroblasts by 1,25-dihydroxyvitamin D3 in vitro - implications for arthritis. In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D - chemistry, biology and clinical applications of the steroid hormone. Proceedings of the Tenth Workshop on Vitamin D, Strasbourg, France, May 24-29, 1997:877-8.
37. Civitelli R. The role of vitamin D metabolites in the treatment of osteoporosis. Calcif Tissue Int 1995;57:409-14.
38. Goulding NJ. Corticosteroids - a case of mistaken identity? Br J Rheumatol 1998;37:477-80.
39. Bondeson J. The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen Pharmacol 1997;29: 127-50.
40. Scheven BA, van der Veen MJ, Damen CA, Lafeber FP, Van Rijn HJ, Bijlsma JW et al. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3. J Bone Miner Res 1995;10: 874-80.
41. May KP, West SG, McDermott MT, Huffer WE. The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 1994;37: 201-6.